Status:
RECRUITING
tDCS and Spasticity in Stroke Patients
Lead Sponsor:
Riphah International University
Conditions:
Stroke
Eligibility:
All Genders
30-70 years
Phase:
NA
Brief Summary
Multiple research has worked on tDCS and its impact on stroke. But none have studied the effects of tDCS on stroke in relation to the different stages of stroke like mild, moderate, moderate to severe...
Detailed Description
Multiple noninvasive brain stimulation is also introduced over the few years regarding their impact on spasticity, tDCS being the most common due to its effects on spasticity. There are multiple struc...
Eligibility Criteria
Inclusion
- Stroke for more than 6 months.
- Both genders.
- Spasticity score ≥1 at modified ashworth scale.
- National Institutes of Health Stroke Scale (NIHSS) for severity level; Mild (1-4), Moderate (5-15), Moderate to Severe (16-20), Severe (21-42)
Exclusion
- Have any metallic implant including intracranial electrode, pacemaker, surgical clip.
- Any symptoms effecting understanding of instructions.
- Any neurological disorder
Key Trial Info
Start Date :
October 1 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 31 2025
Estimated Enrollment :
56 Patients enrolled
Trial Details
Trial ID
NCT06598683
Start Date
October 1 2024
End Date
July 31 2025
Last Update
March 24 2025
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Pakistan Railway General Hospital
Rawalpindi, Punjab Province, Pakistan, 466000
2
Pakistan Railway Hospital
Rawalpindi, Punjab Province, Pakistan